A phase 1b study of the anticancer stem cell agent demcizumab (DEM), pemetrexed (PEM), and carboplatin (CARBO) in pts with first-line nonsquamous NSCLC. This is an ASCO Meeting Abstract from the 2014 ...
The cancer stem cell (CSC) concept posits that a subpopulation of neoplastic cells with stem-cell properties — particularly the capacity to self-renew and give rise to various more differentiated cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback